Avandia is prescribed for patients who suffer from type 2 diabetes but the consequences of the medicine are potentially more fatal. The drug causes severe heart conditions from blockage, angina to insufficient blood being pumped. FDA specialists have allegedly found that 83,000 cardiac arrests have been a result of the medicine. The AMA has said that prolonged use for almost a year can result in heart failure.
Since the report issued by the AMA in 2007, the FDA issued a public safety warning to make the masses aware of the health hazards. However no further actions were taken. Many people were angered and insisted for recall. In 2008, an advocacy group for consumers, called ‘Public Citizen’, filed an appeal with FDA for the recall of Avandia. The group conducted its own investigation and identified 14 instances of failure of liver and nearly twelve deaths when they examined a small control group of users of Avandia. This autonomous research reinforced the findings of earlier studies.
However, this did not result in recall of the medicine despite the attention that was drawn to the harmful nature of Avandia. Other organizations that were revered to be the source of reliable information stepped in and dropped the medication from the statements of the remedial measures of type 2 diabetes and its treatment.
Avandia contributed to $1.1 billion in 2009 for Glaxo, based in London, which was only one third of the total profit it had generated before reports were made in 2007 about the 43 percent increase in the possibility of cardiac arrest. Many legal cases are pending against the drug. It is hard to make a case against a drug that is not withdrawn from the market, but all the attention might be enough to push Avandia into oblivion or at least force the manufacturers to reexamine the key ingredients.
More Articles :